DENPHARMA Trademark

Trademark Overview


On Thursday, July 15, 2021, a trademark application was filed for DENPHARMA with the United States Patent and Trademark Office. The USPTO has given the DENPHARMA trademark a serial number of 90831662. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2024. This trademark is owned by DEN PHARMA INC.. The DENPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of opioid dependence; antibacterials, namely, antibacterial cleaners, antibacterial hand lotions, and antibacterial pharmaceuticals; pharmaceutical agents for the treatment of respiratory ailments, prevention of endometrial hyperplasia and secondary amenorrhea; anti-viral disinfectants; anti-infectives; vitamins; dietary and nutritional supplements; antacids; Pharmaceutical products and preparations, namely, inhalant anesthetics, injectable contraceptives, nasal spray preparations; topical anesthetic prepared as a sterile aqueous ophthalmic solution; ocular anesthetics; ophthalmic solutions for the treatment of elevated intraocular pressure in individuals with ocular hypertension or open angle glaucoma; hypnotic sedative anesthetic compounds; ophthalmic pharmaceuticals, namely, mydriatics; pharmaceutical preparations for the treatment of respiratory conditions; oral analgesics; oral analgesics in solution or liquid form; analgesic preparati...
denpharma

General Information


Serial Number90831662
Word MarkDENPHARMA
Filing DateThursday, July 15, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 23, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of opioid dependence; antibacterials, namely, antibacterial cleaners, antibacterial hand lotions, and antibacterial pharmaceuticals; pharmaceutical agents for the treatment of respiratory ailments, prevention of endometrial hyperplasia and secondary amenorrhea; anti-viral disinfectants; anti-infectives; vitamins; dietary and nutritional supplements; antacids; Pharmaceutical products and preparations, namely, inhalant anesthetics, injectable contraceptives, nasal spray preparations; topical anesthetic prepared as a sterile aqueous ophthalmic solution; ocular anesthetics; ophthalmic solutions for the treatment of elevated intraocular pressure in individuals with ocular hypertension or open angle glaucoma; hypnotic sedative anesthetic compounds; ophthalmic pharmaceuticals, namely, mydriatics; pharmaceutical preparations for the treatment of respiratory conditions; oral analgesics; oral analgesics in solution or liquid form; analgesic preparations; spinal anesthetics; anti-diarrheal agents; prescription synthetic narcotics; anxiolytics; anti-seizure medications; topical anesthetics; pharmaceutical preparations for treatment of arsenic, gold and mercury poisoning and acute lead poisoning; pharmaceutical preparations for relief of nasal congestion, sinus pressure and sinus headaches; nasal spray preparations; topical preparations for the treatment of arthritis, joint pain, back pain, foot pain and muscle pain; preparations for the relief of pain; pain relief medications; magnesium supplements; preparations for the relief of arthritis and joint pain; cough suppressants and expectorants; cough drops and syrups; preparations for treating symptoms of common colds and influenza; medicated foot creams; skin care lotions and skin care ointments; medicated skin creams and lotions, namely, anti-itch creams; medicated tinctures and ointments for lip and skin care; eye drops; lubricant eye drops; contact lens wetting solutions; veterinary pain relief medications, namely, topical anesthetics and sedatives; veterinary medical eye wash; pharmaceutical products and preparations for fertility, namely, fertility enhancement preparations, and birth control, namely contraceptive preparations; pharmaceutical products and preparations for treating wounds and poisoning; pharmaceuticals and pharmaceutical preparations, namely, antibacterial pharmaceuticals for protection against bacterial agents resistant to antibiotics; pharmaceutical products and preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical products and preparations for the treatment of respiratory conditions; analgesic preparations; pharmaceutical products and preparations for the prevention and treatment of infectious parasitic diseases, neoplasms, diseases of blood or blood-forming organs or disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases and disorders; pharmaceutical products and preparations for the prevention and treatment of mental and behavioral disorders in the nature of diseases of the nervous system, neurological diseases and disorders, and neurodegenerative diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 20, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDEN PHARMA INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDallas, TX 75234

Party NameDEN PHARMA INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDallas, TX 75234

Trademark Events


Event DateEvent Description
Monday, March 18, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 18, 2024ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 3, 2023SOU EXTENSION 1 GRANTED
Thursday, August 3, 2023SOU EXTENSION 1 FILED
Thursday, August 3, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, January 1, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, September 22, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, August 23, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 3, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 28, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 28, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, June 24, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, June 24, 2022FINAL REFUSAL E-MAILED
Friday, June 24, 2022FINAL REFUSAL WRITTEN
Wednesday, June 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 8, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 8, 2022NON-FINAL ACTION E-MAILED
Friday, April 8, 2022NON-FINAL ACTION WRITTEN
Monday, April 4, 2022ASSIGNED TO EXAMINER
Monday, September 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 19, 2021NEW APPLICATION ENTERED